Inspiring Journey: Baby Aasmika Receives Lifesaving Zolgensma Gene Therapy After Raising ₹8.41 Cr on Impact Guru
In a heartwarming turn of events, Baby Aasmika, an infant suffering from Spinal Muscular Atrophy (SMA) Type 1, has successfully undergone Zolgensma gene therapy, one of the most expensive and groundbreaking treatments in the world. Her treatment was made possible after a massive crowdfunding campaign raised a staggering ₹8.41 crore on the medical crowdfunding platform…